Source: Eur Respir J 2009; 33: 1216-1219
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robibaro B., Funk G-C., Dekan G., Demetriou D., Ziesche R., Winkler S., Block L.H.. Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania. Eur Respir J 2009; 33: 1216-1219

Member's Comments

No comment yet.

Related content which might interest you: Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017 Year: 2018 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis Source: ERJ Open Res, 5 (4) 00051-2019; 10.1183/23120541.00051-2019 Year: 2019 Gram-negative enterobacteria in the etiological structure of COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Microbiology of non-CF bronchiectasis Source: Eur Respir Mon 2011; 52: 68-96 Year: 2011 Acinetobacter lwoffii and lactococcus lactis strains isolated from cowsheds of traditional farms suppress allergic airway inflammation in a mouse model of experimental asthma Source: Eur Respir J 2007; 30: Suppl. 51, 736s Year: 2007 The prevalence of antimicrobial resistance of P. aeruginosa, K. pneumoniae, E. coli, A. baumanii in Ukraine Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Characterizing Neisseria spp. as novel respiratory pathobionts in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis Source: Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020 Year: 2020